Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | 258,136 | reported | 27 Apr 2026 | tx 1+64,988 |
| Aura Biosciences, Inc. | 21,000 | reported | 31 Mar 2025 | tx 2+50,000 |
| Fusion Pharmaceuticals Inc. | 0 | reported | 04 Jun 2024 | tx 2+34,000−34,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2026 | GRANT_AWARD | TAKEDA PHARMACEUTICAL CO LTD | 64,988 | 0.00 USD | |
| 31 Mar 2025 | GRANT_AWARD | Aura Biosciences, Inc. | 21,000 | 0.00 USD | |
| 31 Mar 2025 | GRANT_AWARD | Aura Biosciences, Inc. | 29,000 | 0.00 USD | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 34,000 | — | deriv |
| 16 Oct 2023 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 34,000 | 0.00 USD | deriv |